Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer
- Cantiello, Francesco
- Russo, Giorgio I
- Vartolomei, Mihai Dorin
- Farhan, Abdal Rahman Abu
- Terracciano, Daniela
- Musi, Gennaro
- Lucarelli, Giuseppe
- Di Stasi, Savino M
- Hurle, Rodolfo
- Serretta, Vincenzo
- Busetto, Gian Maria
- Scafuro, Chiara
- Perdonà, Sisto
- Borghesi, Marco
- Schiavina, Riccardo
- Cioffi, Antonio
- De Berardinis, Ettore
- Almeida, Gilberto L
- Bove, Pierluigi
- Lima, Estevao
- Ucciero, Giuseppe
- Matei, Deliu Victor
- Crisan, Nicolae
- Verze, Paolo
- BATTAGLIA, Michele
- Guazzoni, Giorgio
- Autorino, Riccardo
- Morgia, Giuseppe
- Damiano, Rocco
- de Cobelli, Ottavio
- Mirone, Vincenzo
- Shariat, Shahrokh F
- Ferro, Matteo
Publication date
January 2018
DOIAbstract
In this study, we defined a risk score (the SIM score) based on the measurement of routine systemic inflammatory markers. This score can identify patients with high-grade bladder cancer not invading the muscular layer who are more likely to suffer from tumor recurrence and progression. Therefore, the score could be used to select patients who might benefit from early bladder removal
Add to ORKG